The plaintiffs rely extensively on a New York Times article that ran in April.

S&P Global analysts continue to see drug costs as the top everyday concern.

A divided panel objected to the limits a trial court judge set on the evidence presented.

Ron Wyden and Bernie Sanders asked the company to brief their committee staffers.

Brokers and distributors predict chaos. CMS asks why they took so long to sue.

HealthEquity's CEO predicts plan participants' adoption rates will rise as the firm's relationships with health plans mature.

The not-for-profit hospital group will get physicians from SCP Health as well as nurses and physician assistants.

Brokers and other business associates should talk to the covered entities, not the people affected, officials say.